NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

被引:139
|
作者
McDonagh, TA
Holmer, S
Raymond, I
Luchner, A
Hildebrant, P
Dargie, HJ
机构
[1] Univ Glasgow, Royal Infirm, Dept Cardiol, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G31 2ER, Lanark, Scotland
[3] Univ Copenhagen, Friedrichsberg Hosp, Copenhagen, Denmark
关键词
epidemiological studies; heart failure; cardio-renal distress;
D O I
10.1016/j.ejheart.2004.01.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many studies have shown that the B-type natriuretic peptides (BNP and NT-proBNP) are proven diagnostic markers for heart failure due to left ventricular systolic dysfunction. The manner in which they are to be used is still being unravelled; most single centre studies have chosen the best concentration of the peptide on ROC analysis as their cut-point resulting in numerous different values for both BNP and NT-proBNP appearing in the literature. We report a different approach of defining an age and sex corrected abnormal concentration for NT-proBNP, derived from normal individuals within a large sample of 3051 subjects pooled from three European epidemiology studies and applying that to the entire population to detect HF and LVD. Three thousand and fifty one subjects were studied. Of these 10% (305) had significant LVD and 3.1% (94) had HE The median concentrations of NT-proBNP (IQR) in normals, those with LVD and in heart failure subjects were 20 pg/ml (10.30), 117.3 pg/ml (28.145) and 269.6 pg/ml (54.323), P<0.001, respectively. The area under the ROC curve for NT-proBNP for the detection of 'heart failure' was 0.85 and 0.69 for LVD. NT-proBNP was an independent predictor of the presence of HF on multivariate analysis. An abnormal NT-proBNP was defined as being > 95th centile for normals, age and sex corrected, and diagnosed HF with a sensitivity of 75% and a negative predictive value of 99%. In an additional analysis in a breathless subgroup of our population, in 30% a raised NT-proBNP concentration could be explained by HF due to LVD, in another 64% the high BNP level was associated with some other structural of functional cardiac abnormality or renal impairment. We were unable to assign a possible cause to the high NT-proBNP values in 5.9% of this breathless subgroup of the population. An abnormal NT-proBNP concentration is an accurate diagnostic test both for the exclusion of HF in the population and in ruling out LVD in breathless subjects. An elevated NT-proBNP merely indicates the presence of 'cardio-renal distress' and should prompt referral for further investigation. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 50 条
  • [1] Utility of NT-PROBNP in pleural fluids in the diagnosis of heart failure
    Lepe Balsalobre, E.
    Rubio Sanchez, R.
    Viloria Penas, M. D. M.
    Moro Ortiz, A.
    CLINICA CHIMICA ACTA, 2019, 493 : S173 - S174
  • [2] NT-proBNP levels and hypertension.: Their importance in the diagnosis of heart failure
    Rivera, M
    Talèns-Visconti, R
    Salvador, A
    Bertomeu, V
    Miró, V
    de Burgos, FG
    Climent, V
    Cortés, R
    Payá, R
    Pérez-Boscá, JL
    Mainar, L
    Jordán, A
    Sogorb, F
    Cosín, J
    Mora, V
    Diago, JL
    Marín, F
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (05): : 396 - 402
  • [3] N-T pro-BNP and the diagnosis of heart failure: A pooled analysis of three European epidemiological studies
    McDonagh, TA
    Raymond, I
    Holmer, S
    Luchner, A
    Hildebrandt, P
    Dargie, HJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 143A - 144A
  • [4] NT-proBNP for the diagnosis of acute heart failure: where are we now?
    Mendez Bailon, Manuel
    Munoz Rivas, Nuria
    MEDICINA CLINICA, 2008, 131 (19): : 739 - 740
  • [5] Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure
    Hammerer-Lercher, Angelika
    Halfinger, Bernhard
    Sarg, Bettina
    Mair, Johannes
    Puschendorf, Bernd
    Griesmacher, Andrea
    Guzman, Norberto A.
    Lindner, Herbert H.
    CLINICAL CHEMISTRY, 2008, 54 (05) : 858 - 865
  • [6] NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure
    Pan, Yesheng
    Li, Dongjiu
    Ma, Jian
    Shan, Li
    Wei, Meng
    MEDICINE, 2017, 96 (51)
  • [7] NT-proBNP: An independent predictor of heart failure
    Bibbins-Domingo, K
    Ali, S
    Wu, AH
    Whooley, MA
    CIRCULATION, 2006, 113 (08) : E333 - E333
  • [8] Sequential Evaluation of NT-proBNP in Heart Failure
    Armstrong, Paul W.
    Zheng, Yinggan
    Troughton, Richard W.
    Lund, Lars H.
    Zhang, Jian
    Lam, Carolyn S. P.
    Westerhout, Cynthia M.
    Blaustein, Robert O.
    Butler, Javed
    Hernandez, Adrian F.
    Roessig, Lothar
    O'Connor, Christopher M.
    Voors, Adrian A.
    Ezekowitz, Justin A.
    JACC-HEART FAILURE, 2022, 10 (09) : 677 - 688
  • [9] NT-PROBNP GUIDED HEART FAILURE THERAPY
    Januzzi, James L., Jr.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S174 - S174
  • [10] NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
    Januzzi, JL
    van Kimmenade, R
    Lainchbury, J
    Bayes-Genis, A
    Ordonez-Llanos, J
    Santalo-Bel, M
    Pinto, YM
    Richards, M
    EUROPEAN HEART JOURNAL, 2006, 27 (03) : 330 - 337